SEC 13F Intelligence

Granahan Investment Management, LLC / VKTX

Granahan Investment Management, LLC’s Viking Therapeutics Inc Position

Does Granahan Investment Management, LLC own Viking Therapeutics Inc (VKTX)? Yes — 332.2K shares worth $11M (+0.52% of its 13F portfolio) as of Q1 2026, up from 235.6K shares the prior filed quarter.

Position Value
$11M
Q1 2026
Shares
332.2K
% of Portfolio
+0.52%
Quarters Held
9
currently held

Position History VKTX

Reported value by quarter
Q1 ’24: $26MQ1 ’24Q2 ’24: $20MQ3 ’24: $21MQ3 ’24Q4 ’24: $12MQ1 ’25: $9MQ1 ’25Q2 ’25: $8MQ3 ’25: $5MQ3 ’25Q4 ’25: $8MQ1 ’26: $11MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026332.2K$11M+0.52%
Q4 2025235.6K$8M+0.35%
Q3 2025189.5K$5M+0.20%
Q2 2025305.1K$8M+0.33%
Q1 2025368.0K$9M+0.44%
Q4 2024305.6K$12M+0.51%
Q3 2024325.3K$21M+0.81%
Q2 2024378.7K$20M+0.80%
Q1 2024318.9K$26M+0.92%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Granahan Investment Management, LLC’s full portfolio or all institutional holders of VKTX.